Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eris Pharmaceuticals is an Australian-based pharmaceutical company that specializes in the development, registration, and commercialization of a diverse portfolio of healthcare products. Founded in 2009 and headquartered in Melbourne, the company has established a robust presence across the Middle East, Africa, and the CIS regions. Their product range includes high-quality branded generics, innovative medical devices, and over-the-counter (OTC) solutions across various therapeutic areas such as cardiology, gastroenterology, and dermatology. Eris Pharmaceuticals leverages strategic partnerships and a deep understanding of regulatory environments to provide affordable and effective medical treatments to emerging markets. The company operates in compliance with international standards, including the Australian Therapeutic Goods Administration (TGA) guidelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eris Pharmaceuticals.